Intellectual Property Protection in Corporate M&A

A merger between two pharma technology leaders puts the most valuable trade secrets of both companies into rooms full of people from the other side. The deal's value is exactly what a leak would destroy.

The protection program ran for the full deal window: clean-team barriers in space and staffing, a standing sweep schedule, and visitor auditing that admitted no exceptions. Nine thousand IP assets crossed the finish line with zero leak events.

Barriers, sweeps and no exceptions until closing.